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Abstract. For rapid intraoperative diagnosis of lymph node 
micrometastasis, we refined the rapid immunohistochemistry 
method by combining anti-cytokeratin antibody-labeled 
nanocrystal beads with rapid hematoxylin and eosin (H&E) 
staining on the same section, referred to as the rapid double 
staining (RDS) technique. Two frozen-section slices each were 
obtained from 372 lymph nodes of 100 breast cancer patients. 
We performed RDS for 1 slide and rapid H&E staining for the 
other. The results were compared with the corresponding final 
pathological data obtained from the permanent specimens. 
For specimens from patients with pN1(mi) as determined 
by final pathological examination, the false-negative rate 
was 33.3% for rapid H&E staining and 16.7% for RDS. For 
specimens from patients with pN0(i+) as determined by final 
pathological examination, the false-negative rate was 80% for 
rapid H&E staining and 0% for RDS. These results indicate 
that RDS is superior to conventional rapid H&E staining for 
intraoperative diagnosis of nodal micrometastasis and isolated 
tumor cells.
Introduction
The presence or absence of lymph node metastasis is an 
important prognostic factor in breast cancer (1). However, 
the significance of lymph node micro-involvement remains 
unclear (2,3). In the UICC TNM classification (7th edition), 
micrometastases are defined as metastases with a long diam-
eter of 2 mm or less as observed in section samples; those 
with diameters of 0.2 mm or less are defined as isolated tumor 
cells (ITCs). While ITCs are not thought to affect outcomes, 
micrometastases are considered to be a prognostic factor (4).
In clinically node-negative breast cancer, the presence or 
absence of lymph node metastasis is primarily determined by 
sentinel node (SN) biopsy (5). When omitting axillary dissec-
tion based on SN biopsy results, detection of micrometastases 
using a rapid diagnostic method would be beneficial (4). 
However, the accuracy of conventional intraoperative diag-
nosis remains low. Although the false-negative rate could be 
reduced by preparing several 2-mm-thick sections, the diag-
nostic potential of frozen sections is limited (6).
One of the current commonly used techniques for 
intraoperative diagnosis of nodal metastasis is rapid immu-
nohistochemistry (IHC). Rapid IHC aims to improve the 
accuracy of frozen-section diagnoses. However, this method 
has drawbacks that make it difficult to use for the diagnosis of 
micrometastases and ITCs (7). Qualitative diagnosis of cells 
is poor given the lack of cytoplasmic staining, and sections 
used for rapid IHC are prepared differently from those used 
for hematoxylin and eosin (H&E) staining (8).
Therefore, we refined the rapid IHC technique using 
nanocrystal beads labeled with an anti-cytokeratin antibody 
for determining lymph node metastasis (9). This method uses 
a double-staining procedure that combines rapid fluorescent 
immunostaining and H&E staining on the same section. We 
refer to this method as ‘RDS’ (rapid double staining with H&E 
and immuno-nanocrystal bead staining) (9). Using lymph 
nodes extracted from breast cancer patients who had under-
gone SN biopsies in our unit, we compared the false-negative 
rates of the RDS and rapid H&E methods.
Materials and methods
Nanocrystal beads and antibody. We used quantum dots 
(QDs) Qdot®655 (Invitrogen, Carlsbad, CA, USA) as nano-
crystal beads (9). The cytokeratin 8 antibody SC-8020 (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA) was adopted as 
the anti-cytokeratin antibody (8).
RDS procedure. QD labeling with anti-cytokeratin antibodies 
was carried out according to the specified protocol (Fig. 1) (10). 
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Stock solutions of antibody-labeled QDs were stored at 4˚C. The 
procedure for RDS was as follows. Frozen samples were first 
rapidly fixed for 30 sec in 100% acetone, followed by rinsing 
with running water. After rinsing in phosphate-buffered saline 
(PBS) for 1 min, a few drops of the 10-fold diluted QD solu-
tion were applied to the samples, which were then incubated 
at 37˚C for 20 min. After rinsing with PBS for 1 min, samples 
were stained with hematoxylin for 10 sec. Samples were then 
rinsed with running water for 30 sec, followed by staining with 
eosin for 3 sec. Finally, the samples were fixed in alcohol for 
1 min and sealed with xylene (Table I). The entire staining 
procedure can be completed within 30 min (8).
Observation of specimens. Fixed samples were examined 
under a fluorescence microscope BX51-3 (Olympus, Tokyo, 
Japan) equipped with a U-MWU2 optical filter (Olympus) (11). 
Both the bright-field views and the fluorescence views of the 
same microscopic field are able to be observed with the BX51-3. 
The observation method for the RDS slide was as follows. We 
first looked for any fluorescent sites with the fluorescent view. 
If any such site was found, we switched to bright-field obser-
vation and examined whether it was a metastatic focus. Both 
bright-field and fluorescent images are able to be observed 
merely by switching filters.
Patients and lymph nodes. Samples used in the present study 
were from 372 lymph nodes from 100 patients who suffered 
from breast cancer. Patients underwent partial mastectomy 
and SN biopsy without neoadjuvant chemotherapy between 
October 2007 and March 2009. Our institute adopts combina-
tion mapping with radioisotope (RI) and blue dye to identify 
SN in breast cancer patients (12). For the RI tracer, we perform 
subcutaneous injection around the tumor; for the dye, Patent 
Blue is subcutaneously injected beneath the areola.
For SNs dissected during surgery, multiple 2-mm slices 
were cut parallel to the central slice containing the hilus. Two 
sets of sections for pathological diagnosis during surgery, one 
for conventional rapid H&E staining and the other for RDS, 
were prepared in the pathology department of our hospital. We 
compared the false-negative rates of the rapid H&E and RDS 
methods using the final pathology results from permanent 
preparations as a reference. The final pathology results were 
categorized as metastasis (pN1), micrometastasis [pN1(mi)], 
or isolated tumor cells [pN0(i+)], according to the UICC 
classification (7th edition). In our pathology department, 
the diagnostic procedure for final pathology results involves 
diagnosing metastases using H&E-stained, formalin-fixed 
permanent preparations; for lymph nodes diagnosed as n0, 
including ITCs, cytokeratin immunostaining is then carried 
out to confirm negative diagnoses of metastasis (12).
Ethical guidelines of the study. All the patients were fully 
informed in regards to the purpose and content of the study 
and provided informed consent for participation in the study, 
according to the Helsinki Declaration.
Results
Detection of metastasis by RDS. Fig. 2 shows the images of 
metastatic lymph nodes stained by RDS. In the bright-field 
observation, metastatic foci of lymph nodes were observed 
Figure 1. The Qdot® and antibody kit procedure.
Table I. Procedure for the hematoxylin and eosin and immuno-
nanocrystal bead staining.
Step Procedure
  1 Acetone solution for 1 min
  2 Rinse with water for 30 sec
  3 Rinse with PBS one time
  4 Staining with labeled Qdot diluted 20 times
 for 20 min at 37˚C
  5 Rinse with PBS twice
  6 Hematoxylin for 10 sec
  7 Rinse with water for 30 sec
  8 Eosin for 3 sec
  9 Rinse with water for 30 sec
10 99% alcohol for 1 min
11 Enclose in xylene
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with H&E staining. For observation of fluorescence, the 
cytoplasm of cancer cells was clearly stained orange by the 
QDs, while normal lymphocytes appeared green due to eosin 
staining. This provides a clear contrast that facilitates the 
diagnosis of metastasis.
RDS images of micrometastasis in lymph nodes are 
shown in Fig. 3. As in pN1(mi) nodes, making a diagnosis of 
metastasis is easy. Fig. 4 shows ITC images detected by RDS. 
The diagnosis of ITCs are known to be somewhat difficult 
by bright-field observation; however, in our series ITCs were 
readily diagnosable with observation of epifluorescence given 
the clear contrast between cancerous and normal cells.
Fig. 5 shows plasma cells in lymph nodes. Since anti-
cytokeratin antibodies react with plasma cells, they sometimes 
Figure 2. Images of metastatic lymph nodes in the breast cancer cases. (A) Transmission bright-field observation; (B) epifluorescence.
Figure 3. Images of micrometastatic lymph nodes in the breast cancer cases. (A) Transmission bright-field observation; (B) epifluorescence.
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appear orange under epifluorescence microscopy, as do cancer 
cells. However, H&E staining facilitates determination of the 
absence of cancer cells when viewed under bright-field obser-
vation.
Diagnosis of metastasis by examining SN in breast cancer. Of 
the 100 patients, 21 (21.0%) were diagnosed as pN1 in the final 
pathological examination. Of the 372 lymph nodes, metastasis 
was identified in 29 (7.8%). While all 21 cases were diagnosed 
as having metastatic disease by rapid H&E staining, 20 cases 
were diagnosed as having metastatic disease by RDS. Thus, 
the false-negative rate was 0% for rapid H&E staining and 
4.8% for RDS. The reason for the false-negative case by RDS 
was lack of a metastatic focus in the RDS frozen section; the 
metastatic focus was likely lost from the section in the slicing 
step (Fig. 6A).
Of the 100 patients, 6 (6.0%) were diagnosed as pN1(mi) 
in the final pathological examination. Of the 372 lymph 
nodes, metastasis was identified in 6 (1.61%). We were able 
to detect metastatic foci in 4 of these 6 cases with rapid H&E 
Figure 5. Images of plasma cells in the breast cancer cases. (A) Transmission bright-field observation; (B) epifluorescence.
Figure 6. Comparison of the false-negative rates between rapid hematoxylin and eosin (HE) staining and the rapid double staining (RDS) methods. (A) Samples 
from 21 patients diagnosed with N1 by final pathological examination. (B) Samples from 6 patients diagnosed with N1(mi) by final pathological examination. 
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staining; metastatic foci were detected in 5 of the cases with 
RDS. Thus, the false-negative rate was 33.3% for rapid H&E 
staining and 16.7% for RDS. With regard to the one case in 
which metastasis was not detected by RDS, the specimen was 
ultimately determined to be from a case with ITCs rather than 
micrometastasis (Fig. 6B).
Of the 100 patients, 5 (5.0%) were diagnosed as pN0(i+) in 
the final pathological examination. Of the 372 lymph nodes, 7 
(1.88%) had ITCs. While rapid H&E staining detected ITCs in 
only 1 of the 5 cases, RDS detected ITCs in all 5 cases. Thus, 
the false-negative rate was 80.0% for rapid H&E staining and 
0% for RDS. RDS failed to detect ITCs in 1 lymph node, 
probably due to a lack of cancer cells in the frozen section 
(Fig. 6C).
Discussion
In the present study, we demonstrated that RDS was superior 
to conventional rapid H&E staining for the diagnosis of ITCs. 
This method, therefore, represents a promising improvement 
in the accuracy of frozen section diagnosis of sentinel-node 
biopsy.
Needless to say, in order to achieve more accurate diagnoses 
of metastases, it will be necessary to improve the intraopera-
tive diagnostic effectiveness of the procedure (13,14).
In the present study, the accuracy of diagnosis of intra-
operative rapid H&E was very high (91%). To improve the 
accuracy of intraoperative diagnosis of lymph node metas-
tases, we cut lymph nodes into 2-mm slices and prepared 
multiple slices (6). However, for breast cancer, the accuracy 
of intraoperative frozen section diagnosis of metastatic lymph 
node lesions (metastatic lesions >0.2 mm) varies among 
studies (1). For example, Ali et al (1) reported the accuracy to 
be 76%, while Tanis et al (15) found it to be 74%. To increase 
the accuracy of detection of lymph node metastases, multiple 
intraoperative immunohistochemical evaluation methods 
using anti-cytokeratin antibodies have been developed (16,17). 
Many of these staining procedures, however, are complicated, 
time-consuming and therefore impractical.
In order to observe the immunostaining results more 
clearly, we used a fluorescence immunostaining method (9). 
Traditionally, fluorescence immunostaining has been available 
only as a two-step procedure in which a luminescence reagent 
is added after antibody molecules are bound to cells. Such 
a technique has multiple drawbacks: the procedure is time-
consuming and the period of light emission is short (8).
To overcome these drawbacks, we developed RDS, which 
has the following characteristics: a convenient one-step proce-
dure for immunostaining, very clear staining results, rapid 
H&E and immunofluorescence staining of the same slice of 
specimen, easy staining procedures, no requirement for special 
equipment except for a fluorescence microscope and low cost.
Using the RDS method, the limitations of the fluorescence 
immunostaining method were overcome by using nanocrystal 
beads, which allow for clearer visualization and a shorter 
procedure time. We used QDs as nanocrystal beads. The 
energy acceptor modules consisted of CdSe/ZnS semicon-
ductor nanocrystals coated with a polymer shell containing 
5-7 biotin molecules per dot on their surfaces (18). The beads 
also have stable, bright optical characteristics; furthermore, 
through a maleimide-thiol binding reaction, they can be 
conjugated with any antibody (18). Various QDs are available, 
each with a different emission spectrum (19). Herein, we used 
QD655, which produces maximal emission at 655 nm. The 
color of QD655 fluorescence is red, clearly contrasting with 
normal lymphocytes, which appear green upon eosin staining. 
Based on the procedure reported in a study by Ishii et al (3), 
we conjugated these QDs to anti-cytokeratin 8/18 antibodies 
(SC-8020).
As frozen-section diagnosis at our hospital is highly effec-
tive and accurate overall, the advantage of RDS in this study 
was limited to the diagnosis of ITCs (4). Nevertheless, we 
believe that RDS has sufficient value for clinical use. In many 
institutions, if the diagnosis of ITCs can be established by intra-
operative rapid diagnostic methods applied to lymph nodes, 
axillary lymph node dissection is not routinely performed (1). 
Galimberit et al (20) reported, however, that 15-19% of non-
sentinel nodes were found to be metastatic in cases where ITCs 
were present in SNs. In a study by de Boer et al (4), the pres-
ence or absence of micrometastases and ITCs was also shown 
to be associated with survival in patients who did not receive 
postoperative adjuvant chemotherapy. Additionally, a case in 
which RDS failed to find micrometastasis was diagnosed as 
having ITCs. We speculate that this false-negative case was 
attributable to issues related to preparation of the sections; a 
micrometastasis is very small and a section does not always 
represent the maximal cutting size. Therefore, the diagnosis 
should be made intraoperatively in any case, although whether 
lymph node dissection is needed for patients with ITCs is a 
separate issue that needs to be addressed (21,22).
For rapid diagnosis of lymph node metastasis, one-step 
nucleic acid amplification (OSNA) assay was recently devel-
oped (23). With this method, the expression level of cytokeratin 
19 (CK19) mRNA is assessed with specific primers, and 
amplification and detection of CK19 mRNA can be achieved 
in ~30 min. Tamaki et al (24) reported the sensitivity and 
specificity of the OSNA assay for detection of metastases to 
be 95 and 97.1%, respectively.
Some metastatic lymph nodes of breast cancer patients, 
however, are CK19-negative. The OSNA assay may provide 
false-negative results in such cases (24). Parikh et al (25) 
reported lack of CK19 expression in 20.5% of 158 breast 
carcinomas in a tissue microarray. Moreover, they found a 
statistically significant association between lack of CK19 
expression and the triple-negative (TN) phenotype (30% of TN 
breast cancers were CK19-negative). Since the RDS method 
also detects the expression level of cytokeratin 8/18 (CK8/18), 
CK8/18-negative metastatic lymph nodes would display no 
fluorescence signals. While no such cases were observed in 
this study, our RDS method would avoid such false-negative 
results by switching filters for bright-field observation, 
allowing morphological detection of cancerous structures by 
H&E staining of the same section.
Moreover, in the OSNA assay, sample lymph nodes must be 
homogenized in lysis buffer. Thus, generally, when performing 
a rapid intraoperative diagnosis, half of the lymph node sample 
is used for the OSNA assay and the other half for imprint 
cytology (24). For the samples used for OSNA, morphological 
information regarding lymph node metastases is completely 
lost during the lysis step and consequently cannot be used later 
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to confirm the diagnosis. Unlike the OSNA assay, the RDS 
method allows morphological examination for the detection 
of metastases, because the same frozen sections are used for 
fluorescence immunostaining and H&E staining.
RDS would also be useful for SN biopsy in gastrointestinal 
cancer cases. Since these patients cannot be re-operated, the 
presence or absence of SN micrometastases must be diagnosed 
intraoperatively.
As long as tumor cells are present in the sections, the 
RDS method facilitates the diagnosis of ITCs even when 
involvement is minimal. Our RDS method is clinically useful 
for examination of the SN biopsy of breast cancers and can 
contribute to the intraoperative diagnosis of lymph node 
metastases and standardization of cancer treatments.
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